Bioluminescence Ventures Emerges from Stealth with $477M AUM

SAN FRANCISCO–(BUSINESS WIRE)–Bioluminescence Ventures (“BLV”), a biotech venture firm investing in next-generation medicines, today announced its emergence from stealth with $477M in assets under management across two funds: Bioluminescence Ventures Fund I, L.P., and Bioluminescence Ventures Fund II, L.P. The firm is supported by an investor base that includes U.S….
Click here to view original post